Minerva Neurosciences (NERV) Misses Q1 EPS by 4c May 5, 2026 10:18AM
Citizens Starts Minerva Neurosciences (NERV) at Market Outperform Apr 15, 2026 02:23AM
Minerva Neurosciences names Jim O'Connor as chief business officer Apr 2, 2026 04:05PM
Minerva Neurosciences presents safety data on roluperidone-olanzapine combo Mar 25, 2026 04:05PM
Minerva Neurosciences (NERV) PT Raised to $7 at H.C. Wainwright Mar 12, 2026 06:39AM


Mar 11, 2026 09:26AM Minerva Neurosciences (NERV) files $200M mixed shelf
Mar 11, 2026 08:41AM Minerva Neurosciences (NERV) Misses Q4 EPS by 2540c
Dec 23, 2025 04:09PM Minerva Neurosciences (NERV) files for 94.6M share offering by selling stockholders
Nov 19, 2025 08:32AM Minerva Neurosciences adds Dr. Inderjit Kaul to board
Nov 5, 2025 04:13PM Minerva Neurosciences (NERV) Misses Q3 EPS by 1c
Aug 14, 2025 05:46PM Minerva Neurosciences (NERV) Tops Q2 EPS by 47c
May 13, 2025 07:50AM Minerva Neurosciences (NERV) Tops Q1 EPS by 57c
Feb 25, 2025 04:32PM Minerva Neurosciences (NERV) Misses Q4 EPS by 153c
Nov 5, 2024 07:41AM Minerva Neurosciences (NERV) Tops Q3 EPS by 398c
Aug 7, 2024 06:49AM Minerva Neurosciences (NERV) PT Lowered to $5 at H.C. Wainwright
Aug 6, 2024 08:02AM Minerva Neurosciences (NERV) Misses Q2 EPS by 12c